Living with HIV | Body Positive News
Living with HIV

WHO recommends starting ART within a week of diagnosis with HIV

28Jul17
Everyone diagnosed with HIV should be offered the option to start treatment within seven days of diagnosis and everyone who feels ready should have the option to start treatment on the day of diagnosis, the World Health Organisation (WHO) has recommended. The new guidance was issued on the opening day of the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris.
Read More...

HIV Transmission and prevention

01May17
HIV transmission has reached a new record high of 244 cases in New Zealand in 2016. This follows a consistent upward trend that has been happening since 2011. Most of the cases 159 or 65% were amongst men who have sex with men with the majority 98 or 61.6% of these infections taking place within New Zealand. Amongst the Heterosexual population there were 42 new diagnoses with 11 of these infections being local.

For people not diagnosed and infected locally they may have been living with HIV for a period of time and have been engaged in care elsewhere and have just returned to New Zealand (from Australia or the UK for example) and their diagnosis is defined as “new” to New Zealand. We will always have these types of new diagnosis as people are allowed to migrate to NZ while living with HIV – which is a good thing. Read More...

Body Positive is extending their Peer Navigation Programme to provide local support to people living with HIV throughout New Zealand

PeerNavigation_400
No one understands the reality of living with HIV better than someone who experiences it every day. Peer Navigators - specially trained members of the community who are living with HIV - support others who are learning to cope with the daily challenges of living with HIV. Read More...

Undetectable equals Uninfectious (U=U)

25Jan17
Body Positive is celebrating the most significant development in the HIV world since the advent of effective combination therapy 20 years ago – people living with HIV who maintain undetectable viral loads through adherence to treatment can confidently declare to their sexual partners “I’m not infectious!”  Read More...

Pharmac funds new HIV drug in New Zealand - Dolutegravir (Tivicay)

Dolutegravir (Tivicay)
Body Positive is thankful to Pharmac for adding Dolutegravir (Tivicay) to its list of Anti-Retroviral for the treatment of HIV effective November 1st 2016. Dolutegravir is a relatively new drug which was approved by Medsafe in 2014. Read More...

Efavirenz appears to be associated with elevated suicide risk in START trial

efavirenz had an increased risk of suicidal and self-injuring behaviour
Participants in the START treatment-timing trial who took antiretroviral regimens containing efavirenz had an increased risk of suicidal and self-injuring behaviour than those not using efavirenz, though the number of events was small and the effect was mainly seen among people with a prior psychiatric diagnosis, according to research presented at the 21st International AIDS Conference (AIDS 2016) last month in Durban, South Africa. Read More...

New Health Navigator at Body Positive - Sally Cartwright

23Feb16
Body Positive is delighted to welcome Sally Cartwright to the team in the new position of Health Navigator. This is a new project that was made possible through seed funding from the NZAF and ongoing funding from the ViiV Positive Action fund in the UK.

Sally will work with members of the community who are living with and at risk of HIV to identify their needs and aspirations, and then link and co-ordinate access to health care and other support services. Sally is a reliable and stable resource and contact for clients as they move through the health system and access support services. Sally’s role is especially important in assisting people through their initial HIV diagnosis.
Read More...

START trial finds that early treatment improves outcomes for people with HIV

03Jun15
Starting at a CD4 count over 500 cells/mm3 is safer than waiting till 350 cells/mm3.

A major international randomised clinical trial has found that people living with HIV have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral treatment (ART) sooner, when their CD4 cell count is above 500 cells/mm3, instead of waiting until their CD4 cell count drops below 350 cells/mm3. Read More...

US guidelines shift to integrase-based combinations for first-line treatment: Atripla relegated due to side effects

20May15_1
The latest update of the leading US treatment guidelines, produced by a panel from the Department of Health and Human Sciences (DHHS) was published online on 9 April 2015.

These comprehensive, evidence-based guidelines now run to almost 300 pages including over 30 tables previous. This is the first update since May 2014. Read More...

HIV positive workers take less than a week off

20May15
The majority of people living with HIV take less than four days off work a year but still find it hard to get protection, research has shown.

The study by medical financial advisers Unusual Risks showed that 89 per cent of HIV positive people took less than a week in sick leave a year.

Meanwhile, 74 per cent said they had taken less than the national average of four days. Read More...